Weber Alan W Maintains Position in Quorum Health Corporation (QHC)
Weber Alan W maintained its stake in Quorum Health Corporation (NYSE:QHC) during the second quarter, Holdings Channel reports. The institutional investor owned 148,683 shares of the company’s stock at the end of the second quarter. Weber Alan W’s holdings in Quorum Health Corporation were worth $617,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in QHC. Howard Hughes Medical Institute boosted its stake in Quorum Health Corporation by 8.4% in the first quarter. Howard Hughes Medical Institute now owns 18,321 shares of the company’s stock worth $100,000 after buying an additional 1,415 shares during the period. Thrivent Financial for Lutherans boosted its stake in Quorum Health Corporation by 6.4% in the fourth quarter. Thrivent Financial for Lutherans now owns 15,910 shares of the company’s stock worth $116,000 after buying an additional 960 shares during the period. TFS Capital LLC bought a new stake in Quorum Health Corporation during the first quarter worth approximately $125,000. Alambic Investment Management L.P. boosted its stake in Quorum Health Corporation by 145.5% in the first quarter. Alambic Investment Management L.P. now owns 24,800 shares of the company’s stock worth $135,000 after buying an additional 14,700 shares during the period. Finally, KCG Holdings Inc. bought a new stake in Quorum Health Corporation during the first quarter worth approximately $142,000. Institutional investors own 87.88% of the company’s stock.
Quorum Health Corporation (NYSE QHC) opened at 3.06 on Thursday. The stock’s market capitalization is $92.73 million. Quorum Health Corporation has a 52-week low of $2.54 and a 52-week high of $9.46. The firm’s 50-day moving average is $3.73 and its 200-day moving average is $5.37.
Quorum Health Corporation (NYSE:QHC) last issued its quarterly earnings results on Wednesday, August 9th. The company reported ($0.42) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.66) by $0.24. Quorum Health Corporation had a negative return on equity of 60.49% and a negative net margin of 16.94%. The firm had revenue of $530.15 million during the quarter, compared to the consensus estimate of $513.50 million. During the same period last year, the company earned ($0.82) earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. Analysts predict that Quorum Health Corporation will post ($1.63) earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Weber Alan W Maintains Position in Quorum Health Corporation (QHC)” was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2017/08/10/weber-alan-w-maintains-position-in-quorum-health-corporation-qhc.html.
QHC has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Quorum Health Corporation from a “hold” rating to a “buy” rating and set a $4.50 target price for the company in a research note on Saturday, July 22nd. Credit Suisse Group reiterated a “neutral” rating and issued a $3.25 target price (down from $5.00) on shares of Quorum Health Corporation in a research note on Wednesday, May 17th. Finally, Morgan Stanley started coverage on shares of Quorum Health Corporation in a research note on Tuesday, June 6th. They issued an “underweight” rating and a $3.00 target price for the company. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $4.57.
In related news, SVP Shaheed Koury purchased 8,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 25th. The stock was purchased at an average cost of $3.56 per share, with a total value of $30,260.00. Following the completion of the acquisition, the senior vice president now directly owns 88,680 shares in the company, valued at $315,700.80. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Thomas Daniel Miller purchased 185,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 18th. The shares were bought at an average cost of $2.85 per share, with a total value of $527,250.00. Following the completion of the acquisition, the insider now owns 814,139 shares of the company’s stock, valued at $2,320,296.15. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 197,500 shares of company stock valued at $568,190. Corporate insiders own 4.70% of the company’s stock.
About Quorum Health Corporation
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).
Want to see what other hedge funds are holding QHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quorum Health Corporation (NYSE:QHC).
Receive News & Ratings for Quorum Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.